Utilizamos cookies para comprender de qué manera utiliza nuestro sitio y para mejorar su experiencia. Esto incluye personalizar el contenido y la publicidad. Para más información, Haga clic . Si continua usando nuestro sitio, consideraremos que acepta que utilicemos cookies.
American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay test kits, including point-of-collection tests for drugs of abuse.
The COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood / Serum / Plasma) is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to 2019 Novel Coronavirus in human whole blood, serum or plasma.
The Logix Smart COVID-19 Detection Kit (US FDA EUA/CE-IVD) is an in vitro diagnostic test that uses the company’s patented CoPrimer technology for the qualitative detection of the RNA from SARS-CoV-2 coronavirus (COVID-19). The test operates using a single step real-time reverse transcriptase polymerase chain reaction (RT-PCR) process in lower respiratory tract fluids (e.g. bronchoalveolar lavage, sputum, tracheal aspirate), and upper respiratory tract fluids (e.g. nasopharyngeal and oropharyngeal swabs) from suspected COVID-19 patients.
The Rapid COVID-19 Antigen Test (Swab) is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) swab specimens directly from individuals who are suspected of Covid-19 by their healthcare provider.
American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay test kits, including point-of-collection tests for drugs of abuse.
The Rapid TOX Cup II (2nd Gen) incorporates collection and testing of drugs of abuse in urine specimens in a compact device. The CLIA waived and 510K cleared Rapid TOX Cup II for OTC use can test up to 18 different drugs of abuse simultaneously and provide results in five minutes.
The ABMC Xpress Cup is a CLIA-waived drug test cup offering an all-in-one urine based test that can be utilized in practically any drug screening scenario. The drug test cup can detect 3 to 14 drugs of abuse with the option to add adulteration testing and customization into numerous configurations to meet any drug testing needs.
The Rapid COVID-19 Antigen Test (Swab) is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) swab specimens directly from individuals who are suspected of Covid-19 by their healthcare provider.
The Rapid TOX Cup II (2nd Gen) incorporates collection and testing of drugs of abuse in urine specimens in a compact device. The CLIA waived and 510K cleared Rapid TOX Cup II for OTC use can test up to 18 different drugs of abuse simultaneously and provide results in five minutes.
The ABMC Xpress Cup is a CLIA-waived drug test cup offering an all-in-one urine based test that can be utilized in practically any drug screening scenario. The drug test cup can detect 3 to 14 drugs of abuse with the option to add adulteration testing and customization into numerous configurations to meet any drug testing needs.
The Rapid COVID-19 Antigen Test (Swab) is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) swab specimens directly from individuals who are suspected of Covid-19 by their healthcare provider.
The Logix Smart COVID-19 Detection Kit (US FDA EUA/CE-IVD) is an in vitro diagnostic test that uses the company’s patented CoPrimer technology for the qualitative detection of the RNA from SARS-CoV-2 coronavirus (COVID-19). The test operates using a single step real-time reverse transcriptase polymerase chain reaction (RT-PCR) process in lower respiratory tract fluids (e.g. bronchoalveolar lavage, sputum, tracheal aspirate), and upper respiratory tract fluids (e.g. nasopharyngeal and oropharyngeal swabs) from suspected COVID-19 patients.
The COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood / Serum / Plasma) is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to 2019 Novel Coronavirus in human whole blood, serum or plasma.
The OralStat (2nd Gen) is a revolutionary test for the detection of drugs of abuse in oral fluid, providing results in minutes. It combines the convenience of oral fluid collection with the sensitivity, accuracy and precision of a laboratory-based test.
The ABMC XPress Dip is a CLIA-Waived Dip Test that offers a quick, precise and practical solution for on-site drug screening, producing results in minutes, with an assay line providing a simple interpretation. It can test from 1 to 14 drugs of abuse and can be customized into numerous configurations to meet most drug testing needs.
The Rapid ONE is a test cassette designed to detect a single drug of abuse in a human urine specimen and provides results in three-five minutes. The tamper-proof test device’s built-in procedural control and ease of use make it a cost-effective solution for situations in which a specific drug of abuse is a concern.